Yanwei Wu

1.2k total citations
25 papers, 936 citations indexed

About

Yanwei Wu is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Yanwei Wu has authored 25 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Yanwei Wu's work include Heme Oxygenase-1 and Carbon Monoxide (4 papers), Immune Response and Inflammation (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Yanwei Wu is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (4 papers), Immune Response and Inflammation (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Yanwei Wu collaborates with scholars based in China. Yanwei Wu's co-authors include Wei Tang, Jianping Zuo, Chunlan Feng, Fenghua Zhu, Pei‐Lan He, Heng Li, Shijun He, Haoyu Wang, Bing Wu and Xiaoqian Yang and has published in prestigious journals such as The FASEB Journal, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Yanwei Wu

24 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanwei Wu China 15 378 377 127 119 113 25 936
Haiyun Liu United States 16 420 1.1× 377 1.0× 99 0.8× 61 0.5× 69 0.6× 31 1.1k
Qiao Zhou China 21 208 0.6× 401 1.1× 289 2.3× 135 1.1× 73 0.6× 103 1.2k
Yan He China 20 314 0.8× 772 2.0× 142 1.1× 109 0.9× 108 1.0× 118 1.5k
Lianbo Xiao China 17 507 1.3× 679 1.8× 102 0.8× 358 3.0× 81 0.7× 43 1.5k
Ko‐Jen Li Taiwan 20 385 1.0× 339 0.9× 145 1.1× 285 2.4× 97 0.9× 78 1.2k
Chieh‐Yu Shen Taiwan 17 287 0.8× 352 0.9× 113 0.9× 219 1.8× 66 0.6× 38 945
Young Ok Jung South Korea 19 266 0.7× 324 0.9× 96 0.8× 284 2.4× 40 0.4× 39 1.2k

Countries citing papers authored by Yanwei Wu

Since Specialization
Citations

This map shows the geographic impact of Yanwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Wu more than expected).

Fields of papers citing papers by Yanwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Wu. The network helps show where Yanwei Wu may publish in the future.

Co-authorship network of co-authors of Yanwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanwei Wu. A scholar is included among the top collaborators of Yanwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwei Wu. Yanwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Yaxian, Jingyao Li, Xia Zhao, Yanwei Wu, & Liang Chen. (2025). CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity. Frontiers in Immunology. 15. 1519671–1519671. 14 indexed citations
2.
3.
Wu, Yanwei, Juliang Xiao, Yu Tian, et al.. (2024). Vibration suppression of balls in different contact states during mirror milling of curved thin-walled parts based on magnetic follow-up support fixture. Journal of Manufacturing Processes. 131. 2323–2339. 5 indexed citations
4.
Yu, Ling, et al.. (2024). Evaluation of Bonding Behavior between Engineered Geopolymer Composites with Hybrid PE/PVA Fibers and Concrete Substrate. Materials. 17(15). 3778–3778. 8 indexed citations
5.
Wang, Haoyu, Xi Lin, Rong Zhou, et al.. (2023). Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases. Acta Pharmacologica Sinica. 44(8). 1687–1700. 23 indexed citations
6.
Xu, Mengmeng, Bing Wu, Chunlan Feng, et al.. (2022). Hemin protects against Zika virus infection by disrupting virus-endosome fusion. Antiviral Research. 203. 105347–105347. 10 indexed citations
7.
Bai, Fang, Xi Lin, Haoyu Wang, et al.. (2022). Hemin protects UVB-induced skin damage through inhibiting keratinocytes apoptosis and reducing neutrophil infiltration. Journal of Photochemistry and Photobiology B Biology. 238. 112604–112604. 10 indexed citations
8.
Wang, Haoyu, Yanwei Wu, & Wei Tang. (2022). Methionine cycle in nonalcoholic fatty liver disease and its potential applications. Biochemical Pharmacology. 200. 115033–115033. 16 indexed citations
9.
Wu, Bing, Mengmeng Xu, Fan Chen, et al.. (2021). STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion. Acta Pharmacologica Sinica. 43(8). 2055–2066. 95 indexed citations
10.
Qi, Qing, Qian Li, Hongwen Zhu, et al.. (2021). Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathway. Pharmacological Research. 169. 105678–105678. 14 indexed citations
11.
Huang, Suling, Yanwei Wu, Zhuohui Zhao, et al.. (2021). A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage. Metabolism. 120. 154797–154797. 73 indexed citations
12.
Wu, Bing, Yanwei Wu, Chunlan Feng, et al.. (2021). Heme supplementation ameliorates lupus nephritis through rectifying the disorder of splenocytes and alleviating renal inflammation and oxidative damage. International Immunopharmacology. 94. 107482–107482. 4 indexed citations
13.
Li, Heng, Fan Chen, Chunlan Feng, et al.. (2019). Inhibition of phosphodiesterase‐4 attenuates murine ulcerative colitis through interference with mucosal immunity. British Journal of Pharmacology. 176(13). 2209–2226. 74 indexed citations
14.
Lu, Huimin, Heng Li, Fan Chen, et al.. (2019). RIPK1 inhibitor ameliorates colitis by directly maintaining intestinal barrier homeostasis and regulating following IECs-immuno crosstalk. Biochemical Pharmacology. 172. 113751–113751. 18 indexed citations
15.
Zhang, Zongwang, Yanwei Wu, Bing Wu, et al.. (2019). DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models. Arthritis Research & Therapy. 21(1). 290–290. 18 indexed citations
16.
Wu, Bing, Yanwei Wu, & Wei Tang. (2019). Heme Catabolic Pathway in Inflammation and Immune Disorders. Frontiers in Pharmacology. 10. 825–825. 62 indexed citations
17.
Qi, Qing, Yansheng Xu, Xiaoqian Yang, et al.. (2018). Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacologica Sinica. 39(10). 1633–1644. 162 indexed citations
18.
Wu, Yanwei, Shijun He, Luyao Zhang, et al.. (2015). Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation. Cellular and Molecular Immunology. 13(3). 379–390. 94 indexed citations
19.
Wu, Yanwei, Wei Tang, & Jianping Zuo. (2015). Development of artemisinin drugs in the treatment of autoimmune diseases. Science Bulletin. 61(1). 37–41. 23 indexed citations
20.
He, Shijun, Zemin Lin, Yanwei Wu, et al.. (2013). Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacologica Sinica. 35(2). 219–229. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiyun Liu Breakdown of academic impact, for papers by Qiao Zhou Breakdown of academic impact, for papers by Yan He Breakdown of academic impact, for papers by Lianbo Xiao Breakdown of academic impact, for papers by Ko‐Jen Li Breakdown of academic impact, for papers by Chieh‐Yu Shen Breakdown of academic impact, for papers by Young Ok Jung
Rankless by CCL
2026